W103L (p.Trp103Leu) variant of NPHS2 (Podocin)
W103L (p.Trp103Leu) in NPHS2 (Podocin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
W103L (p.Trp103Leu) variant details
- p.Trp103Leu
- NCI-TCGA Cosmic COSV1008
- cosmic curated COSV10085
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available